mitral valve insufficiency/obesitat

L'enllaç es desa al porta-retalls

Trieu el tipus d'ordenació

Pàgina 1 des de 64 resultats

Moderate ischemic mitral regurgitation (IMR) and metabolic syndrome: where are we now and where are we going?

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND The metabolic syndrome appears to affect 10% to 25% of adult population worldwide. Several studies have described the association between metabolic syndrome and ischaemic heart disease, however, none linked metabolic syndrome to ischemic mitral regurgitation, a serious clinical problem

Circulating concentrations of insulin-like growth factor-1 in dogs with naturally occurring mitral regurgitation.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Insulin-like growth factor-1 (IGF-1), which mediates most effects of growth hormone, has effects on cardiac mass and function, and plays an important role in the regulation of vascular tone. In humans, an inverse relationship between degree of heart failure (HF) and circulating IGF-1 concentrations

How do we use imaging to aid considerations for intervention in patients with severe mitral regurgitation?

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Increasing life expectancy and comorbid conditions, like obesity, especially in industrialized countries, have led to Valvular Heart Disease (VHD) becoming a major epidemic. Mitral valve disease currently accounts for nearly 10% of Valvular Heart Disease in industrialized countries worldwide. It is

Subclinical carotid atherosclerosis predicts all-cause mortality and cardiovascular events in obese patients with negative exercise echocardiography.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Obesity is a major health problem due to its high prevalence. The relationship between obesity and cardiovascular disease is unclear. Some studies agree that certain conditions associated with obesity, such as physical inactivity or cardiovascular risk factors, are responsible for

Aortic valvular regurgitation: prevalence and clinical characteristics in a predominantly obese adult population not taking anorexigens.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND We recently reported the prevalence of aortic regurgitation (AR) by Doppler echocardiography (echo) in obese subjects to be higher than in some previous reports. OBJECTIVE To describe the prevalence of AR in an obese population not taking anorexigens as a function of demographic

An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND The appetite-suppressant drug fenfluramine, usually given in combination with phentermine, has been reported to be associated with cardiac valvular regurgitation. Concern has been raised that the d-enantiomer of fenfluramine, dexfenfluramine, may also cause this problem. We were able to

Impact of obesity on adverse in-hospital outcomes in patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip® procedure - Results from the German nationwide inpatient sample

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Background and aim: The number of percutaneous edge-to-edge mitral regurgitation (MR) valve repairs with MitraClip® implantations increased exponentially in recent years. Studies have suggested an obesity survival paradox in patients with cardiovascular diseases.

Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression, and need for mitral valve surgery.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Patients with mitral valve prolapse (MVP) may develop severe mitral regurgitation (MR) and require valve surgery. Preliminary data suggest that high body weight and blood pressure might add to the irreversible factors of older age and male gender in increasing risk of these complications. Fifty-four

Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study).

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Evidence suggesting that mitral regurgitation (MR) may be induced by appetite suppressant medications heightens the importance of understanding the prevalence and correlates of MR, especially its relation to obesity, in population-based samples. MR was assessed by color Doppler echocardiography in

Cardiac valve evaluation and adipokine levels in obese women treated with sibutramine.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

OBJECTIVE The aims of present study were 1) to evaluate cardiac valve characteristics, 2) to determine the plasma concentrations of fibrinogen, high sensitivity C-reactive protein (hsCRP), adiponectin, and tumor necrosis factor-alpha (TNF-alpha) in the obese women before and after 19 months

Characterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

The 5-HT2C receptor agonist lorcaserin (Belviq®) has been Food and Drug Administration (FDA) approved for the treatment of obesity. The present study is a back translational investigation into the effect of 28-day lorcaserin treatment in a diet-induced obesity (DIO) model using male, Sprague-Dawley

The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND After case reports of cardiac-valve abnormalities related to the use of appetite suppressants were published, we undertook a study to determine the prevalence of the problem using transthoracic echocardiography. METHODS We examined patients who had taken dexfenfluramine alone,

Computed tomography angiography for imaging results of neochordal mitral valve repair.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND Degenerative mitral regurgitation is currently the most frequent indication for mitral valve repair. OBJECTIVE To visualize and assess the mid-term results of mitral valve repair with neochordae implantation, using computed tomography angiography (CTA) imaging. METHODS The CTA with ECG

Natural history of valvular regurgitation using side-by-side echocardiographic analysis in anorexigen-treated subjects.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

In 1997, the US Food and Drug Administration (FDA) reported valvular regurgitation (aortic regurgitation [AR] mild or greater and/or mitral regurgitation [MR] moderate or greater) in 32.8% of patients treated with anorexigens. This study sought to determine the natural history of valvular

[Diagnostic value of the transesophageal Doppler echocardiography].

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Transesophageal echocardiography has been proven to be of particular value in all patients with transthoracic echocardiograms of low quality related to pulmonary emphysema, obesity and chest deformation as well as in intensive care unit patients. Similarly, transesophageal Doppler echocardiography

Anterior
1
2
3
4
5
Pròxim

Uneix-te a la nostra
pàgina de Facebook

Herbal & Natural Medicine

La base de dades d’herbes medicinals més completa avalada per la ciència

Funciona en 55 idiomes
Cures a base d'herbes recolzades per la ciència
Reconeixement d’herbes per imatge
Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
Llegiu publicacions científiques relacionades amb la vostra cerca
Cerqueu herbes medicinals pels seus efectes
Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades